Since hypertension is a strong risk factor for hemorrhagic stroke [54], it is speculated that lowering blood pressure with SGLT2 inhibitors results in greater risk reductions in hemorrhagic stroke compared to other types of strokes. Here, SLC5A2 is linked to hemorrhagic stroke.